3D model is for representation purpose only.
.
.
![]()  | 
                         ![]()  | 
                         ![]()  | 
                         ![]()  | 
                         ![]()  | 
                    
                        
|---|---|---|---|---|
| XEEX | Methotrexate | 
| Identification | |
|---|---|
| ConjuPepDB ID |   cpd00846  | 
| Smiles | |
| Inchi Key |   InChIKey=LNDFBCBUTJAAHP-NSOVKSMOSA-N  | 
| Molecular weight |   813.413  | 
| Molecular formula |   C37H55N11O10  | 
| Chemical name | Peptide information | 
| Sequence (one letter) |   XEEX  | 
| Length |   4  | 
| Peptide name |   tripeptide  | 
| External ID | |
|---|---|
| CAS number |   864282-23-5  | 
| Other information | |
|---|---|
| Application |   Anti-inflamatory therapy, osteoarthritis  | 
| Conjugate type |   amide  | 
| Linker |   no  | 
| Small molecule |   Methotrexate  | 
| Small molecule CAS |   59-05-2  | 
| Small molecule structure |   | 
| Structure method |   1H-NMR  | 
| NMR solvent |   DMSO-d6  | 
| Calculated properties | |
|---|---|
| LogP |   -2.08510  | 
| Rotatable bonds |   29  | 
| H bond donor |   6  | 
| H bond acceptor |   16  | 
| Polar surface area (PSA) |   300.45000  | 
| Citations | |||||
|---|---|---|---|---|---|
| ID | Title | Year | Authors | Journal | DOI | 
Synthesis and optimization of hyaluronic acid-methotrexate conjugates to maximize benefit in the treatment of osteoarthritis  | 2010  | Homma, Akie; Sato, Haruhiko; Tamura, Tatsuya; Okamachi, Akira; Emura, Takashi; Ishizawa, Takenori; Kato, Tatsuya; Matsuura, Tetsu; Sato, Shigeo; Higuchi, Yoshinobu; Watanabe, Tomoyuki; Kitamura, Hidetomo; Asanuma, Kentaro; Yamazaki, Tadao; Ikemi, Masahisa; Kitagawa, Hironoshin; Morikawa, Tadashi; Ikeya, Hitoshi; Maeda, Kazuaki; Takahashi, Koichi; Nohmi, Kenji; Izutani, Noriyuki; Kanda, Makoto; Suzuki, Ryohchi  | Bioorganic & Medicinal Chemistry  | ||